IP Library Granted Patent US 12,209,278
Granted Patent B2
US 12,209,278 · App. 17/822,760 · Granted Jan 28, 2025

Accelerated sequencing methods

Inventors: Mark Pratt (Bozeman, MT); Gilad Almogy (Palo Alto, CA); Dumitru Brinza (Montara, CA); Eliane Trepagnier (Oakland, CA); Omer Barad (Mazkeret Batya, IL); Yoav Etzioni (Tel Aviv, IL); Florian Oberstrass (Menlo Park, CA)
Assignee: Ultima Genomics, Inc.
C12Q1/6869C12Q1/6827G16B30/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,209,278
App. No.
17/822,760
Granted
Jan 28, 2025
Kind
B2
Abstract

Described herein are methods of generating a coupled sequencing read pair for a polynucleotide, and methods of analyzing the coupled sequencing read pair. The coupled sequencing read pair can be analyzed to detect polynucleotide variants, including at loci that are not directly sequenced within the coupled sequencing read pair. Other analytical methods can include using coupled sequencing read pairs to construct or validate a consensus sequence. The coupled sequencing read pair may be generated for a polynucleotide by generating sequencing data for a first region by extending a primer using labeled nucleotides; further extending the primer through a second region using nucleotides provided in a second region flow order, wherein primer extension through the second region is faster than primer extension through the first region; and generating sequencing data associated with a sequence of a third region of the polynucleotide by further extending the primer using labeled nucleotides.

Claims (27)

1. A method of synchronizing sequencing primers within a sequencing cluster, comprising:

hybridizing primers to polynucleotide copies within a sequencing cluster;

extending the primers through a first region of the polynucleotide copies using a mixture of labeled and unlabeled nucleotides according to a first region flow cycle;

extending the primers through a second region of the polynucleotide copies using one or more re-phasing flows without detecting incorporation of nucleotides into the primers during the one or more re-phasing flows, wherein a mixture of at least two different types of nucleotide bases is used in each of the one or more re-phasing flows; and

extending the primers through a third region of the polynucleotide copies using labeled nucleotides according to a third region flow cycle, wherein only a single type of nucleotide base is used at a time during a flow of the third region flow cycle.

2. The method of claim 1 , wherein a mixture of three different types of nucleotide bases are used in at least one of the one or more re-phasing flows.

3. The method of claim 1 , wherein a mixture of three different types of nucleotide bases are used in each of the one or more re-phasing flows.

4. The method of claim 1 , wherein the one or more re-phasing flows comprises four or more flow steps.

5. The method of claim 4 , wherein a mixture of three different types of nucleotide bases are used in at least one of the one or more re-phasing flows.

6. The method of claim 5 , wherein a mixture of three different types of nucleotide bases are used in each of the one or more re-phasing flows.

7. The method of claim 4 , wherein the one or more re-phasing flows comprises, in any order:

(i) a first flow comprising a mixture comprising A, C, and G nucleotides and omitting T nucleotides;

(ii) a second flow comprising a mixture comprising T, C, and G nucleotides and omitting A nucleotides;

(iii) a third flow comprising a mixture comprising T, A, and G nucleotides and omitting C nucleotides; and

(iv) a fourth flow comprising a mixture comprising T, A, and C nucleotides and omitting G nucleotides.

8. The method of claim 1 , wherein the one or more re-phasing flows comprises one or more of, in any order, (i) a flow comprising a mixture comprising A and C nucleotides and omitting G and T nucleotides; (ii) a flow comprising a mixture comprising T and G nucleotides, and omitting A and C nucleotides; (iii) a flow comprising a mixture comprising A and G nucleotides and omitting T and C nucleotides; (iv) a flow comprising a mixture comprising T and C nucleotides and omitting A and G nucleotides; (v) a flow comprising a mixture comprising A and T nucleotides and omitting G and C nucleotides; (vi) a flow comprising a mixture comprising C and G nucleotides and omitting A and T nucleotides; (vii) a flow comprising a mixture comprising A, G, and C nucleotides and omitting T nucleotides; (viii) a flow comprising a mixture comprising T, A, and G nucleotides and omitting C nucleotides; (ix) a flow comprising a mixture comprising C, T, and A nucleotides and omitting G nucleotides; or (x) a flow step comprising a mixture of G, C, and T nucleotides and omitting A nucleotides.

9. The method of claim 1 , wherein at least one of the one or more re-phasing flows comprises a mixture of A, C, G, and T nucleotides, wherein three base types are non-terminating nucleotides and one base type comprises a reversible terminator.

10. The method of claim 9 , wherein the one or more re-phasing flows comprises (i) a flow comprising a mixture comprising non-terminating A nucleotides, non-terminating C nucleotides, non-terminating G nucleotides, and T nucleotides comprising a reversible terminator; (ii) a flow comprising a mixture comprising non-terminating T nucleotides, non-terminating A nucleotides, non-terminating C nucleotides, and G nucleotides comprising a reversible terminator; (iii) a flow comprising a mixture comprising non-terminating G nucleotides, non-terminating T nucleotides, non-terminating A nucleotides, and C nucleotides comprising a reversible terminator; or (iv) a flow comprising a mixture comprising non-terminating C nucleotides, non-terminating G nucleotides, non-terminating T nucleotides, and A nucleotides comprising a reversible terminator.

11. The method of claim 1 , comprising generating sequencing data associated with a sequence of the first region by detecting the presence or absence of an incorporated labeled nucleotide while extending the primers through the first region.

12. The method of claim 11 , comprising generating sequencing data associated with a sequence of the third region by detecting the presence or absence of an incorporated labeled nucleotide while extending the primers through the third region.

13. The method of claim 1 , comprising generating sequencing data associated with a sequence of the third region by detecting the presence or absence of an incorporated labeled nucleotide while extending the primers through the third region.

14. The method of claim 1 , wherein at least a portion of the nucleotides used to extend the primers through the second region are unlabeled nucleotides.

15. The method of claim 1 , wherein the nucleotides used to extend the primers through the second region are unlabeled nucleotides.

16. The method of claim 1 , wherein the sequencing cluster is attached to a bead or a flowcell.

17. The method of claim 1 , wherein the polynucleotide copies within the sequencing cluster are substantially identical to each other.

18. The method of claim 1 , wherein the sequencing cluster is formed by bridge amplification or emulsion PCR.

19. The method of claim 1 , wherein the sequencing cluster is formed on a bead by emulsion PCR, and wherein the bead is further attached to a surface.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2026
From: ULTIMA GENOMICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075435/0595 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2022
From: PRATT, MARK; ALMOGY, GILAD; BRINZA, DUMITRU; TREPAGNIER, ELIANE; BARAD, OMER; ETZIONI, YOAV; OBERSTRASS, FLORIAN
To: ULTIMA GENOMICS, INC.
Reel/Frame 061329/0726 →
Continuity (6)
Continuation 17453481 · Nov 3, 2021
Continuation PCTUS2020031163 · May 1, 2020
Provisional Application 62971530 · Feb 7, 2020
Provisional Application 62904274 · Sep 23, 2019
Provisional Application 62842534 · May 3, 2019
Related Publication 20230060685A1 · Mar 2, 2023
References Cited (108)
US 5714320A · Kool · 1998 [cited by applicant]
US 8364417B2 · Chen · 2013 [cited by applicant]
US 8772473B2 · Huang · 2014 [cited by applicant]
US 9428807B2 · Hubbell · 2016 [cited by applicant]
US 9587274B2 · Chen · 2017 [cited by applicant]
US 9817944B2 · Kural · 2017 [cited by applicant]
US 10192024B2 · Chen · 2019 [cited by applicant]
US 10344328B2 · Barbee · 2019 [cited by applicant]
US 11220709B2 · Oberstrass et al. · 2022 [cited by applicant]
US 11220710B2 · Oberstrass et al. · 2022 [cited by applicant]
US 11459609B2 · Pratt et al. · 2022 [cited by applicant]
US 11462300B2 · Bartov et al. · 2022 [cited by applicant]
US 11578363B2 · Oberstrass et al. · 2023 [cited by applicant]
US 11763915B2 · Etzioni et al. · 2023 [cited by applicant]
US 20090053724A1 · Roth · 2009 [cited by applicant]
US 20100093986A1 · Zwick et al. · 2010 [cited by applicant]
US 20100173303A1 · Ronaghi et al. · 2010 [cited by applicant]
US 20110270533A1 · Zhang · 2011 [cited by applicant]
US 20120252682A1 · Zhou · 2012 [cited by applicant]
US 20130090860A1 · Sikora · 2013 [cited by applicant]
US 20130281306A1 · Rigatti et al. · 2013 [cited by applicant]
US 20140052381A1 · Utiramerur · 2014 [cited by applicant]
US 20140315724A1 · Zhou · 2014 [cited by applicant]
US 20150066824A1 · Harris · 2015 [cited by applicant]
US 20150203910A1 · Smith et al. · 2015 [cited by applicant]
US 20160110499A1 · Donnet · 2016 [cited by applicant]
US 20160326579A1 · Olejnik · 2016 [cited by applicant]
US 20170044601A1 · Crnogorac · 2017 [cited by applicant]
US 20170335387A1 · Brinza · 2017 [cited by applicant]
US 20180330051A1 · Hubbell · 2018 [cited by applicant]
US 20180363047A1 · Smith · 2018 [cited by applicant]
US 20190360034A1 · Zhou et al. · 2019 [cited by applicant]
US 20200199666A1 · Gatti-Lafranconi et al. · 2020 [cited by applicant]
US 20200372971A1 · Etzioni · 2020 [cited by applicant]
US 20200377937A1 · Pratt · 2020 [cited by applicant]
US 20200392584A1 · Almogy · 2020 [cited by applicant]
US 20210010075A1 · Oberstrass · 2021 [cited by applicant]
US 20210054442A1 · Pratt et al. · 2021 [cited by applicant]
US 20210147930A1 · Oberstrass et al. · 2021 [cited by applicant]
US 20210147931A1 · Oberstrass et al. · 2021 [cited by applicant]
US 20210366576A1 · Bartov et al. · 2021 [cited by applicant]
US 20220170089A1 · Pratt et al. · 2022 [cited by applicant]
US 20230197197A1 · Bartov et al. · 2023 [cited by applicant]
US 20230313289A1 · Oberstrass et al. · 2023 [cited by applicant]
US 20230343416A1 · Etzioni et al. · 2023 [cited by applicant]
US 20230407385A1 · Barad · 2023 [cited by applicant]
US 20240018599A1 · Barad · 2024 [cited by applicant]
US 20240043918A1 · Barad · 2024 [cited by applicant]
US 20240120025A1 · Etzioni · 2024 [cited by applicant]
US 20240287483A1 · Mazur · 2024 [cited by applicant]
CN 101415839A · 2009 [cited by applicant]
CN 103717753A · 2014 [cited by applicant]
CN 103917654A · 2014 [cited by applicant]
JP 2001517948A · 2001 [cited by applicant]
WO 199844151A1 · 1998 [cited by applicant]
WO 199844152A1 · 1998 [cited by applicant]
WO 2012134602A2 · 2012 [cited by applicant]
WO 2012166742A2 · 2012 [cited by applicant]
WO 2012166742A3 · 2013 [cited by applicant]
WO 2012134602A3 · 2013 [cited by applicant]
WO 2019084158A1 · 2019 [cited by applicant]
WO 2019099886A1 · 2019 [cited by applicant]
WO 2019191003A1 · 2019 [cited by applicant]
WO 2020172197A1 · 2020 [cited by applicant]
WO 2020185790A1 · 2020 [cited by applicant]
WO 2020186243A1 · 2020 [cited by applicant]
WO 2020227137A1 · 2020 [cited by applicant]
WO 2020236630A1 · 2020 [cited by applicant]
WO 2020240025A1 · 2020 [cited by applicant]
WO 2021007495A1 · 2021 [cited by applicant]
WO 2022051296A1 · 2022 [cited by applicant]
WO 2022056296A1 · 2022 [cited by applicant]
WO 2022099270A1 · 2022 [cited by applicant]
WO 2022099271A1 · 2022 [cited by applicant]
WO 2022109574A1 · 2022 [cited by applicant]
WO 2022204685A1 · 2022 [cited by applicant]
WO 2023004421A1 · 2023 [cited by applicant]
WO 2023288319A1 · 2023 [cited by applicant]
WO 2023010069A1 · 2023 [cited by applicant]
WO 2023010131A1 · 2023 [cited by applicant]
WO 2023060091A1 · 2023 [cited by applicant]
WO 2023081653A1 · 2023 [cited by applicant]
WO 2023081883A2 · 2023 [cited by applicant]
WO 2023081883A3 · 2023 [cited by applicant]
WO 2023141430A1 · 2023 [cited by applicant]
WO 2023164505A2 · 2023 [cited by applicant]
WO 2023164505A3 · 2023 [cited by applicant]
WO 2024102889A1 · 2024 [cited by applicant]
Ali, M.M. et al. (2014). “Rolling Circle Amplification: A Versatile Tool For Chemical Biology, Materials Science and Medicine,” Chem. Soc. Rev. 43:3324, 19 pages. [cited by applicant]
Chaisson, M.J. et al. (2009). “De Novo Fragment Assembly With Short Mate Paired Reads: Does The Read Length Matter?,” Genome Research 19:336-346. [cited by applicant]
Dean et al. (2001). “Rapid Amplification Of Plasmid And Phage DNA Using Phi29 DNA Polymerase And Multiply-Primed Rolling Circle Amplification,” Genome Research 11:1095-1099. [cited by applicant]
Depristo, M.A. et al. (May 2011, e-pub. Apr. 10, 2011). “A Framework For Variation Discovery And Genotyping Using Next-Generation DNA Sequencing Data,” Nature Genetics 43(5):491-498, 20 pages. [cited by applicant]
Hwang, S. et al. (Dec. 7, 2015). “Systematic Comparison Of Variant Calling Pipelines Using Gold Standard Personal Exome Variants,” Sci Rep. 5(17875):1-8. [cited by applicant]
International Preliminary Report on Patentability, issued Nov. 2, 2021, for International Patent Application No. PCT/US20/31163, filed May 1, 2020, 12 pages. [cited by applicant]
International Search Report and Written Opinion of the Searching Authority mailed Oct. 9, 2020, for International Patent Application No. PCT/US20/31163, filed May 1, 2020, 18 pages. [cited by applicant]
Invitation to Pay Additional Fees mailed Aug. 3, 2020, for Patent Application No. PCT/US20/31163, filed May 1, 2020, 2 pages. [cited by applicant]
Mielczarek, M. et al. (2016). “Review Of Alignment And SNP Calling Algorithms For Next-Generation Sequencing Data,” J. Appl. Genetics 57:71-79. [cited by applicant]
Miller, J.R. et al. (2010, e-pub. Mar. 6, 2010). “Assembly Algorithms For Next-Generation Sequencing Data,” Genomics 95:315-327. [cited by applicant]
Nielsen, R. et al. (Jun. 2011). “Genotype And SNP Calling From Next-Generation Sequencing Data,” Nature Reviews Genetics 12(6):443-451, 20 pages. [cited by applicant]
Peng, Q. et al. (2019, e-pub. Mar. 18, 2019). “Targeted Single Primer Enrichment Sequencing with Single End Duplex-UMI,” Scientific Reports 9(4810):1-10. [cited by applicant]
Poplin, R. et al. (Jul. 24, 2018, e-pub. Nov. 14, 2017). “Scaling Accurate Genetic Variant Discovery To Tens Of Thousands Of Samples,” BioRxiv, located at https://www.biorxiv.org/content/biorxiv/early/2017/11/14/201178.… [cited by applicant]
Zerbino, D.R. et al. (2008, e-pub. Mar. 18, 2008). “Velvet: Algorithms For De Novo Short Read Assembly Using De Bruijn Graphs,” Genome Research 18:821-829. [cited by applicant]
Zook, J. M. et al. (Apr. 1, 2019). “An Open Resource For Accurately Benchmarking Small Variant And Reference Calls,” Nature Biotechnology 37:561-566, 14 pages. [cited by applicant]
Mitra, R.B. et al. (2003). “Fluorescent in Situ Sequencing on Polymerase Colonies,” Analytical Biochemistry 320:55-65. [cited by applicant]
Somervuo, P. et al. (2018). “BARCOSEL: A Tool for Selecting an Optimal Barcode Set for High-Throughput Sequencing,” BMC Bioinformatics 19:257, 6 pages. [cited by applicant]
U.S. Appl. No. 18/281,930, filed Sep. 13, 2023, by Oberstrass et al. (U.S. Patent Application is not submitted herewith pursuant to the waiver of 37 C.F.R. § 1.98(a)(2)(iii) issued by the Office on Sep. 21, 2004). [cited by applicant]
U.S. Appl. No. 18/651,565, filed Apr. 30, 2024, by Mazur et al. (U.S. Patent Application is not submitted herewith pursuant to the waiver of 37 C.F.R. § 1.98(a)(2)(iii) issued by the Office on Sep. 21, 2004). [cited by applicant]
Van Dijk, E.L. et al. (2018). “The Third Revolution in Sequencing Technology,” Trends in Genetics 34(9):666-681. [cited by applicant]
Cited By (1)
US 12,637,713